The Detection of Galectin-1 in Head and Neck Cancer

Dhanya K. Nambiar, PhD
Published: Monday, May 29, 2017


 Dhanya K. Nambiar, PhD, Stanford University, discusses the detection of Galectin-1 for patients with head and neck cancer.

Galectin-1 can be detected in patient blood samples, Nambiar explains. Patients with head and neck cancer who are treated with radiation demonstrate higher levels of Galectin-1.

If one correlates the Galectin-1 level with the number of T cells in the blood, they are shown to decrease if the patient has received radiation.
 

 Dhanya K. Nambiar, PhD, Stanford University, discusses the detection of Galectin-1 for patients with head and neck cancer.

Galectin-1 can be detected in patient blood samples, Nambiar explains. Patients with head and neck cancer who are treated with radiation demonstrate higher levels of Galectin-1.

If one correlates the Galectin-1 level with the number of T cells in the blood, they are shown to decrease if the patient has received radiation.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x